These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
243 related articles for article (PubMed ID: 29471517)
21. A prospective 5-year follow-up study after limited resection for lung cancer with ground-glass opacity. Sagawa M; Oizumi H; Suzuki H; Uramoto H; Usuda K; Sakurada A; Chida M; Shiono S; Abe J; Hasumi T; Sato M; Sato N; Shibuya J; Deguchi H; Okada Y Eur J Cardiothorac Surg; 2018 Apr; 53(4):849-856. PubMed ID: 29236995 [TBL] [Abstract][Full Text] [Related]
22. Predictors of Pathologic Tumor Invasion and Prognosis for Ground Glass Opacity Featured Lung Adenocarcinoma. Ye T; Deng L; Xiang J; Zhang Y; Hu H; Sun Y; Li Y; Shen L; Wang S; Xie L; Chen H Ann Thorac Surg; 2018 Dec; 106(6):1682-1690. PubMed ID: 30096292 [TBL] [Abstract][Full Text] [Related]
23. Prognostic Significance of Ground-Glass Opacity Components in 5-Year Survivors With Resected Lung Adenocarcinoma. Shigefuku S; Shimada Y; Hagiwara M; Kakihana M; Kajiwara N; Ohira T; Ikeda N Ann Surg Oncol; 2021 Jan; 28(1):148-156. PubMed ID: 32920721 [TBL] [Abstract][Full Text] [Related]
24. Computed tomography features of resected lung adenocarcinomas with spread through air spaces. Toyokawa G; Yamada Y; Tagawa T; Kamitani T; Yamasaki Y; Shimokawa M; Oda Y; Maehara Y J Thorac Cardiovasc Surg; 2018 Oct; 156(4):1670-1676.e4. PubMed ID: 29961590 [TBL] [Abstract][Full Text] [Related]
25. Prognostic impact of tumour spread through air space in radiological subsolid and pure solid lung adenocarcinoma. Zhong Y; Xu Y; Deng J; Wang T; Sun X; Chen D; Wu C; Hou L; Xie H; She Y; Xie D; Chen C Eur J Cardiothorac Surg; 2021 Apr; 59(3):624-632. PubMed ID: 33188689 [TBL] [Abstract][Full Text] [Related]
26. Prognostic implication of consolidation-to-tumor ratio in early lung adenocarcinoma: a retrospective cross-sectional study. Jing W; Liu M; Li W; Li D; Wu Y; Lv F Quant Imaging Med Surg; 2024 May; 14(5):3366-3380. PubMed ID: 38720835 [TBL] [Abstract][Full Text] [Related]
27. Does ground glass opacity-dominant feature have a prognostic significance even in clinical T2aN0M0 lung adenocarcinoma? Nakamura S; Fukui T; Kawaguchi K; Fukumoto K; Hirakawa A; Yokoi K Lung Cancer; 2015 Jul; 89(1):38-42. PubMed ID: 25963638 [TBL] [Abstract][Full Text] [Related]
28. Partly solid pulmonary nodules: waiting for change or surgery outright? Seok Y; Cho S; Kim K; Jheon S Interact Cardiovasc Thorac Surg; 2014 Oct; 19(4):556-60. PubMed ID: 24981106 [TBL] [Abstract][Full Text] [Related]
29. What is the radiological definition of part-solid tumour in lung cancer?†. Matsunaga T; Suzuki K; Takamochi K; Oh S Eur J Cardiothorac Surg; 2017 Feb; 51(2):242-247. PubMed ID: 28119328 [TBL] [Abstract][Full Text] [Related]
30. Pan-Driver-Negatives versus Epidermal Growth Factor Receptor Mutants for C-Stage IA Lung Adenocarcinoma with Ground-Glass Opacity. Li M; Xi J; Zhang H; Jin X; Zhang J; Feng M; Zhan C; Wang Q Ann Thorac Cardiovasc Surg; 2022 Oct; 28(5):320-328. PubMed ID: 35644565 [TBL] [Abstract][Full Text] [Related]
31. Management of Ground-Glass Opacities in the Lung Cancer Spectrum. Zhang Y; Fu F; Chen H Ann Thorac Surg; 2020 Dec; 110(6):1796-1804. PubMed ID: 32525031 [TBL] [Abstract][Full Text] [Related]
32. Surgical Management of Multifocal Ground-Glass Opacities of the Lung: Correlation of Clinicopathologic and Radiologic Findings. Hattori A; Matsunaga T; Takamochi K; Oh S; Suzuki K Thorac Cardiovasc Surg; 2017 Mar; 65(2):142-149. PubMed ID: 26902328 [No Abstract] [Full Text] [Related]
33. Solid component ratio influences prognosis of GGO-featured IA stage invasive lung adenocarcinoma. Sun F; Huang Y; Yang X; Zhan C; Xi J; Lin Z; Shi Y; Jiang W; Wang Q Cancer Imaging; 2020 Dec; 20(1):87. PubMed ID: 33308323 [TBL] [Abstract][Full Text] [Related]
34. Comparison of three measurements on computed tomography for the prediction of less invasiveness in patients with clinical stage I non-small cell lung cancer. Matsuguma H; Oki I; Nakahara R; Suzuki H; Kasai T; Kamiyama Y; Igarashi S; Mori K; Endo S; Yokoi K Ann Thorac Surg; 2013 Jun; 95(6):1878-84. PubMed ID: 23618519 [TBL] [Abstract][Full Text] [Related]
35. Comprehensive Study of Surgical Treated Lung Adenocarcinoma with Ground Glass Nodule Component. Xu Y; Zheng M; Wang N; Wang R Med Sci Monit; 2019 Nov; 25():8492-8498. PubMed ID: 31710020 [TBL] [Abstract][Full Text] [Related]
36. Prediction of pathologic node-negative clinical stage IA lung adenocarcinoma for optimal candidates undergoing sublobar resection. Tsutani Y; Miyata Y; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M J Thorac Cardiovasc Surg; 2012 Dec; 144(6):1365-71. PubMed ID: 22883546 [TBL] [Abstract][Full Text] [Related]
37. Prognostic factors of lung adenocarcinoma manifesting as ground glass nodules larger than 3 cm. Ding H; Wang H; Zhang P; Song N; Chen L; Jiang G Eur J Cardiothorac Surg; 2019 Jun; 55(6):1130-1135. PubMed ID: 30561606 [TBL] [Abstract][Full Text] [Related]
38. Oncologic outcomes of segmentectomy compared with lobectomy for clinical stage IA lung adenocarcinoma: propensity score-matched analysis in a multicenter study. Tsutani Y; Miyata Y; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M J Thorac Cardiovasc Surg; 2013 Aug; 146(2):358-64. PubMed ID: 23477694 [TBL] [Abstract][Full Text] [Related]
39. Delayed cut-end recurrence after wedge resection for pulmonary ground-glass opacity adenocarcinoma despite negative surgical margin. Sekihara K; Yoshida J; Oda M; Oki T; Ueda T; Ito T; Miyoshi T; Aokage K; Tane K; Tsuboi M Gen Thorac Cardiovasc Surg; 2020 Jun; 68(6):644-648. PubMed ID: 31321610 [TBL] [Abstract][Full Text] [Related]
40. How should we manage small focal pure ground-glass opacity nodules on high-resolution computed tomography? A single institute experience. Yamaguchi M; Furuya A; Edagawa M; Taguchi K; Shimamatsu S; Toyokawa G; Toyozawa R; Nosaki K; Hirai F; Seto T; Takenoyama M; Ichinose Y Surg Oncol; 2015 Sep; 24(3):258-63. PubMed ID: 26298200 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]